TTMI insider files Form 144 to sell 25,000 shares valued at $1.01M
Rhea-AI Filing Summary
TTM Technologies (TTMI) Form 144 — The filing notifies a proposed sale of 25,000 common shares through Merrill Lynch on the NASDAQ with an aggregate market value of $1,011,401.28 and total outstanding shares reported as 103,313,274. The filing lists the securities being sold as acquired mainly through restricted stock unit awards (656 on 06/22/2021; 1,838 on 06/22/2023; 12,671 on 06/22/2024) and a performance award (9,835 on 02/22/2024). It also discloses a sale on 06/23/2025 of 13,669 shares for gross proceeds of $496,868.53. The signer certifies they are not aware of any undisclosed material adverse information about the issuer.
Positive
- Detailed acquisition history is disclosed (RSUs and performance awards with dates and quantities)
- Broker and market details provided (Merrill Lynch; NASDAQ; approximate sale date 08/19/2025), supporting transparency
- Signer certifies no undisclosed material adverse information, consistent with Form 144 attestations
Negative
- Significant proposed insider sale of 25,000 shares valued at $1,011,401.28 could represent material insider liquidity
- Recent prior sale on 06/23/2025 of 13,669 shares for $496,868.53 indicates multiple near-term insider dispositions
Insights
TL;DR: Routine insider liquidity event: proposed sale of 25,000 shares (~$1.01M) after prior June sale of 13,669 shares.
The Form 144 documents a proposed sale by an insider or related person of 25,000 common shares via Merrill Lynch on NASDAQ, valued at roughly $1.01 million. The filing also itemizes the original acquisition sources — restricted stock units and a performance award — with specific grant dates and quantities, which provides clear provenance of the shares being sold. A recent sale on 06/23/2025 of 13,669 shares for $496,868.53 is disclosed, indicating recent insider liquidity. This filing is procedural and informational; it does not assert any change in company operations or financial condition.
TL;DR: Disclosure aligns with Rule 144 requirements; no allegations of undisclosed material information are made.
The submission includes required details: broker, sale date, share counts, outstanding shares, aggregate market value, and acquisition history (RSUs and performance awards). The signer affirms lack of undisclosed material adverse information and cites Rule 10b5-1 trading-plan language. From a governance perspective, the form shows standardized compliance with transfer and reporting obligations but does reflect meaningful insider selling activity totaling the proposed 25,000 shares and a recent June sale.
FAQ
What does the Form 144 filed for TTMI disclose about the proposed sale?
What broker and market are identified for the proposed sale?
Does the filing state whether any undisclosed material information exists?